Daejeon, South Korea

Jin Gang Hou


Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2019-2020

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations of Jin Gang Hou in Cancer Treatment

Introduction

Jin Gang Hou is a notable inventor based in Daejeon, South Korea. He has made significant contributions to the field of cancer treatment through his innovative research and patented inventions. With a total of two patents, his work focuses on utilizing ginsenoside compounds for therapeutic applications.

Latest Patents

One of Jin Gang Hou's latest patents is an anticancer adjuvant containing panaxadiol ginsenoside compounds. This invention relates to a pharmaceutical composition that includes protopanaxadiol (PPD) or compound-K as an active ingredient. The anticancer adjuvant is designed to damage mitochondria in cancer cells, thereby enhancing mitochondria-mediated anticancer activity. This approach aims to provide safer treatment options for cancer patients.

Another significant patent is a method for screening regulators of mitochondrial fission. This method utilizes a cell treated with a PPD-type ginsenoside compound. It enables the effective discovery of formulations that can prevent, improve, or treat mitochondria-related diseases. The potential applications of this method are vast, particularly in the development of therapeutic agents for such diseases.

Career Highlights

Jin Gang Hou is affiliated with the Intelligent Synthetic Biology Center, where he continues to advance his research in synthetic biology and cancer treatment. His work is characterized by a commitment to innovation and the pursuit of effective therapeutic solutions.

Collaborations

Jin Gang Hou collaborates with esteemed colleagues, including Chul Hee Choi and Eun Soo Kim. Their combined expertise contributes to the advancement of research in the field of synthetic biology and cancer therapies.

Conclusion

Jin Gang Hou's innovative work in cancer treatment through the development of ginsenoside-based therapies showcases his dedication to improving patient outcomes. His patents reflect a significant step forward in the fight against cancer and related diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…